Riverview Trust Company’s Ingevity NGVT Stock Holding History

Riverview Trust Company’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-24	Closed	-$3K	–	364
2019 Q1	$3K	Buy	+24	New	+$2.41K	﹤0.01%	337

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverview Trust Company's NGVT Position: Q2 2019 in Review

Riverview Trust Company sold out of Ingevity (NGVT) in Q2 2019, closing a stake of 24 shares — an estimated $3K sold.

Riverview Trust Company first reported a position in NGVT in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 334 funds tracked by Wall St. Rank hold NGVT as of Q2 2019.

Riverview Trust Company reported no remaining Ingevity position as of Q2 2019 after selling out during the quarter.
Riverview Trust Company sold 24 Ingevity shares in Q2 2019, an estimated $3K.
Riverview Trust Company first reported a position in Ingevity in Q1 2019 and held it in 1 quarter.
Riverview Trust Company's Ingevity position peaked at $3K in Q1 2019.
334 funds tracked by Wall St. Rank held Ingevity as of Q2 2019.

Based on Riverview Trust Company's 13F filing for Q2 2019, filed 12 Jul 2019.